⌘K

Login Start Free

Home/Filings/4/0000950170-24-075718

4//SEC Filing

Verwiel Frank 4

Accession 0000950170-24-075718

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 5:00 PM ET

Size

4.6 KB

Accession

0000950170-24-075718

Insider Transaction Report

Form 4

Period: 2024-06-17

Intellia Therapeutics, Inc.NTLA

Director

Transactions

Sale
Common Stock
2024-06-17$25.00/sh−1,505$37,625→ 17,948 total

Footnotes (1)

[F1]The reported sale of 1,505 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 7, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0001545794

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 5:00 PM ET
Size: 4.6 KB

View on SEC.gov